Search results
Results from the WOW.Com Content Network
[16] [17] TALEN and CRISPR are the two most commonly used and each has its own advantages. [18] TALENs have greater target specificity, while CRISPR is easier to design and more efficient. [18] The development of the CRISPR-Cas9 gene editing system has effectively halved the amount of time needed to develop genetically modified animals. [19
The development of CRISPR technology has been highly influential in the field of plant biotechnology, and has the potential to revolutionize the future of agriculture. [ 211 ] CRISPR-Cas systems are most commonly introduced into plants by Agrobacterium -mediated transformation, although particle bombardment and protoplast transformation are ...
CRISPR Therapeutics is applying this technology platform to research, develop and commercialize medicines for various diseases including sickle cell disease, beta thalassemia, various cancers, type 1 diabetes, and cardiovascular diseases. [7] The CEO is Samarth Kulkarni, PhD, who joined the company in 2015 as chief business officer.
The company has previously developed vaccines for avian flu, including one used by the US Fish and Wildlife Service to protect California condors in 2023, Zoetis said, noting, “The decision to ...
This is a list of Georgia companies, current and former businesses whose headquarters are, or were, in the U.S. state of Georgia. Companies based in Georgia
The Agricultural Technology Research Program (ATRP) is part of the Aerospace, Transportation and Advanced Systems Laboratory of the Georgia Tech Research Institute. It was founded in 1973 to work with Georgia agribusiness , especially the poultry industry, to develop new technologies and adapt existing ones for specialized industrial needs. [ 1 ]
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
The companies said they have signed a long-term agreement to continue collaborating on the development of mRNA-based vaccines and a license that allows Emcure to use HDT's mRNA technology, ending ...